Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
by
Abad-Franch, Lydia
, Gunawardena, Sriya
, Simpson, Mindy
, Santagostino, Elena
, Yarramaneni, Abhimanyu
, Fijnvandraat, Karin
, Peyvandi, Flora
, Albisetti, Manuela
, Álvarez Román, Maria Teresa
, Yuan, Huixing
, Malec, Lynn
, Dunn, Amy L.
, Königs, Christoph
, Zulfikar, Bulent
, Chan, Anthony K.C.
, Carcao, Manuel
, Wong, Nancy
, d’Oiron, Roseline
, Demissie, Marek
, Staber, Janice M.
, Chou, Sheng-Chieh
in
Adverse events
/ Age
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Bleeding
/ Body weight
/ Caregivers
/ Child
/ Child, Preschool
/ Children
/ Coagulation
/ Coagulation factors
/ Disease prevention
/ Drug Administration Schedule
/ Factor VIII - administration & dosage
/ Factor VIII - adverse effects
/ Factor VIII - immunology
/ Factor VIII - therapeutic use
/ Factor VIII deficiency
/ Genetics
/ Genetics General
/ Hematology
/ Hemophilia
/ Hemophilia A - complications
/ Hemophilia A - drug therapy
/ Hemorrhage - etiology
/ Hemorrhage - prevention & control
/ Humans
/ Infant
/ Joint Diseases - etiology
/ Male
/ Oncology
/ Patients
/ Pediatrics
/ Pediatrics General
/ Pharmacokinetics
/ Quality of Life
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
/ Recombinant Proteins - immunology
/ Recombinant Proteins - therapeutic use
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
by
Abad-Franch, Lydia
, Gunawardena, Sriya
, Simpson, Mindy
, Santagostino, Elena
, Yarramaneni, Abhimanyu
, Fijnvandraat, Karin
, Peyvandi, Flora
, Albisetti, Manuela
, Álvarez Román, Maria Teresa
, Yuan, Huixing
, Malec, Lynn
, Dunn, Amy L.
, Königs, Christoph
, Zulfikar, Bulent
, Chan, Anthony K.C.
, Carcao, Manuel
, Wong, Nancy
, d’Oiron, Roseline
, Demissie, Marek
, Staber, Janice M.
, Chou, Sheng-Chieh
in
Adverse events
/ Age
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Bleeding
/ Body weight
/ Caregivers
/ Child
/ Child, Preschool
/ Children
/ Coagulation
/ Coagulation factors
/ Disease prevention
/ Drug Administration Schedule
/ Factor VIII - administration & dosage
/ Factor VIII - adverse effects
/ Factor VIII - immunology
/ Factor VIII - therapeutic use
/ Factor VIII deficiency
/ Genetics
/ Genetics General
/ Hematology
/ Hemophilia
/ Hemophilia A - complications
/ Hemophilia A - drug therapy
/ Hemorrhage - etiology
/ Hemorrhage - prevention & control
/ Humans
/ Infant
/ Joint Diseases - etiology
/ Male
/ Oncology
/ Patients
/ Pediatrics
/ Pediatrics General
/ Pharmacokinetics
/ Quality of Life
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
/ Recombinant Proteins - immunology
/ Recombinant Proteins - therapeutic use
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
by
Abad-Franch, Lydia
, Gunawardena, Sriya
, Simpson, Mindy
, Santagostino, Elena
, Yarramaneni, Abhimanyu
, Fijnvandraat, Karin
, Peyvandi, Flora
, Albisetti, Manuela
, Álvarez Román, Maria Teresa
, Yuan, Huixing
, Malec, Lynn
, Dunn, Amy L.
, Königs, Christoph
, Zulfikar, Bulent
, Chan, Anthony K.C.
, Carcao, Manuel
, Wong, Nancy
, d’Oiron, Roseline
, Demissie, Marek
, Staber, Janice M.
, Chou, Sheng-Chieh
in
Adverse events
/ Age
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Bleeding
/ Body weight
/ Caregivers
/ Child
/ Child, Preschool
/ Children
/ Coagulation
/ Coagulation factors
/ Disease prevention
/ Drug Administration Schedule
/ Factor VIII - administration & dosage
/ Factor VIII - adverse effects
/ Factor VIII - immunology
/ Factor VIII - therapeutic use
/ Factor VIII deficiency
/ Genetics
/ Genetics General
/ Hematology
/ Hemophilia
/ Hemophilia A - complications
/ Hemophilia A - drug therapy
/ Hemorrhage - etiology
/ Hemorrhage - prevention & control
/ Humans
/ Infant
/ Joint Diseases - etiology
/ Male
/ Oncology
/ Patients
/ Pediatrics
/ Pediatrics General
/ Pharmacokinetics
/ Quality of Life
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
/ Recombinant Proteins - immunology
/ Recombinant Proteins - therapeutic use
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
Journal Article
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Efanesoctocog alfa is an engineered form of factor VIII that overcomes the half-life ceiling imposed by von Willebrand factor. In this study, once-weekly prophylaxis in children led to highly effective bleeding prevention.
Publisher
Massachusetts Medical Society
Subject
/ Age
/ Antibodies, Neutralizing - blood
/ Antibodies, Neutralizing - immunology
/ Bleeding
/ Child
/ Children
/ Drug Administration Schedule
/ Factor VIII - administration & dosage
/ Factor VIII - adverse effects
/ Factor VIII - therapeutic use
/ Genetics
/ Hemophilia A - complications
/ Hemorrhage - prevention & control
/ Humans
/ Infant
/ Male
/ Oncology
/ Patients
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - adverse effects
This website uses cookies to ensure you get the best experience on our website.